ストックスクリーナーアプリを入手
2.12
3.88%
0.08
Incannex Healthcare Inc (IXHL) 最新ニュース
Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board - The Manila Times
Sleep Medicine Pioneer Joins Incannex's Revolutionary OSA Treatment Development - StockTitan
Incannex Healthcare Announces Positive Topline Results from PK Study - Defense World
Incannex Reports Positive Data for OSA Drug Candidate IHL-42X - Sleep Review
Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea - The Manila Times
Incannex Reports Strong Results for Sleep Apnea Drug IHL-42X in Key Clinical Study - StockTitan
Incannex Healthcare faces Nasdaq delisting over market value By Investing.com - Investing.com South Africa
Incannex Healthcare faces Nasdaq delisting over market value - Investing.com
Reviewing Alterity Therapeutics (NASDAQ:ATHE) and Incannex Healthcare (NASDAQ:IXHL) - Defense World
IXHLIncannex Healthcare Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan
Incannex Healthcare Inc. Receives Notice of Listing Deficiency from NasdaqOn January 3, 2025, Incannex Healthcare Inc. (NASDAQ: IXHL) received a written notice from The Nasdaq Stock Market LLC stating that the company is not in compliance with Nasda - Defense World
U.S. Energy (NASDAQ:USEG) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World
Financial Security Advisor Inc. Has $12.95 Million Position in Microsoft Co. (NASDAQ:MSFT) - Defense World
Incannex Healthcare secures shareholder approvals at annual meeting By Investing.com - Investing.com Canada
Incannex Healthcare secures shareholder approvals at annual meeting - Investing.com
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025 - Nanton News
Incannex Completes Key FDA Trial Phase, Advances Anxiety Drug Development | IXHL Stock News - StockTitan
Incannex Healthcare (IXHL) & Its Rivals Critical Review - Defense World
Incannex Healthcare Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com
Incannex Healthcare (NASDAQ:IXHL) Shares Up 5.5% – Still a Buy? - Defense World
Incannex Healthcare (NASDAQ:IXHL) Trading Up 5.5%What's Next? - MarketBeat
Incannex Healthcare Reports Q3 Loss, Secures New Funding - TipRanks
RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up - Seeking Alpha
Incannex Healthcare Inc (IXHL) Quarterly 10-Q Report - Quartzy
Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Incannex Secures $59M Financing, Reports Q1 Results Amid Clinical Trial Progress | IXHL Stock News - StockTitan
Incannex Healthcare names Lou Barbato as chief medical officer - MSN
Incannex appoints new chief medical officer - Investing.com India
Incannex appoints new chief medical officer By Investing.com - Investing.com South Africa
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer - GlobeNewswire
Incannex Healthcare Appoints Dr. Barbato as CMO - TipRanks
Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks - Simply Wall St
Incannex Healthcare secures $3.3 million through debt financing By Investing.com - Investing.com Australia
Incannex Healthcare secures $3.3 million through debt financing - Investing.com
Incannex Healthcare secures A$6.9 million funding By Investing.com - Investing.com Australia
Incannex Healthcare secures A$6.9 million funding - Investing.com
Incannex Provides Business Updates and Progress on OSA Drug Candidate in Phase 2/3 Trials - Sleep Review
Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL) - Invezz
R&D tax breaks buoy Incannex as losses narrow - Green Market Report
Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short Interest - Defense World
Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - The Manila Times
Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat
Incannex Secures Up to $60M in Financing to Support Clinical Trials - Sleep Review
Incannex secures financing deal valued at US$60 million - Mugglehead
0.73%
0.32%
大文字化:
|
ボリューム (24 時間):